{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "contact": "farah.humayun@scai-extern.fraunhofer.de",
      "name": "heme_26675351.bel",
      "version": "1.0.0",
      "authors": "Farah Humayun",
      "description": "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia."
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$",
      "HM": ".*"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": ".*",
      "TimePoint": ".*",
      "Concentration": ".*"
    },
    "annotation_list": {},
    "path": "c:\\users\\syedf\\pycharmprojects\\heme\\curation\\heme_knowledge\\heme_26675351.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "N-acetyl-L-cysteine",
      "id": "5fd2d2d6c0c71461451f5db5ca45d0a86243558150e59ae481c0a84cff8cdda99c1905adb131aa93fd664feb51f531b5c6526cae874af98ca519f6a18f2f1c7c",
      "bel": "a(CHEBI:\"N-acetyl-L-cysteine\")"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "carbon monoxide",
      "id": "f9a3abc538e60a3026dee8cad1fc1437008be2a35790de8c753ee79bbbcc228bb80f6053c1170690621df714e7420bc4d4144d1883eca1753cffae3c0b1a99b4",
      "bel": "a(CHEBI:\"carbon monoxide\")"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "desferrioxamine B",
      "id": "a49da19b69084c675adbb4db4b674aeafc2a35181871492ccfa7c50ce64a6c4abfc8c89f61961fa7652afabff064cadb1f06bd26635ec5728404604b321f72b9",
      "bel": "a(CHEBI:\"desferrioxamine B\")"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "iron(2+)",
      "id": "e426e7ad4ee4d8eb3c018acb75625d794a96811eb659d39bd8f25c4b30632fc8a938eca8397887738ecc384ec5df867e2026de113f002e5cc4490177de0905cd",
      "bel": "a(CHEBI:\"iron(2+)\")"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "biliverdin",
      "id": "1c1df7b129d5a63a47fc79a36894f16edf9e46eeda375a544fab22d339b8ec13a98effcc5a7a66757ea24e35cb0e93dc91496e8cf42cc4d1ba0235d8b5dcbfab",
      "bel": "a(CHEBI:biliverdin)"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "heme",
      "id": "719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc",
      "bel": "a(CHEBI:heme)"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "protoporphyrin",
      "id": "429e9bada2fbbcb3646b72434923d6994f0d82f26507b76f1e7d35440ca98efac39eeae4d55cbd561dc3d140ebe993543d0eae9192b460a68d6e0a9b4e9efdbe",
      "bel": "a(CHEBI:protoporphyrin)"
    },
    {
      "function": "Abundance",
      "namespace": "HM",
      "name": "M1 polarization",
      "id": "ee1ae2c5b982baad95ab68c8cb2de70c6b2741b851792b20634b92339f1714a53e65506f2269bbf376c04c12afed1020caad06c25ca107c9c9985262c6104ff7",
      "bel": "a(HM:\"M1 polarization\")"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Reactive Oxygen Species",
      "id": "431216f8a4f002a0fa83666bebdbd0cd49a0ffe231e9273c5f429fb234b0cb494c5d4db9d46d631375f41adc4b09f76693b427348a2f18e6a281f770c25d338a",
      "bel": "a(MESH:\"Reactive Oxygen Species\")"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate",
      "id": "719830adfd09d0e9dc001b63806cc58af6b5abbe3df66d50a75637b7461ccd38704254c6eab0edf04b2bb34515a38051bf13ee91e0e5e6870cf1a8a5930118ce",
      "bel": "a(MESH:\"ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate\")"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Monocytes",
      "id": "b5c7111e5e19891dea4fafcb9cdc48ed44402d7c029386148be62da514a0b7061634a3ca14d3f04e96bee1afb922bfa9411aeb117e3e7f0c5a602ee58a2fb794",
      "bel": "a(MESH:Monocytes)"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "inflammatory response",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "bel": "bp(GO:\"inflammatory response\")"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Erythrocyte Deformability",
      "id": "aafe5f8fc07e6abe467e9e2c47e0be8c08012664bc30134675ce5df8b3ab3ccc93ed0cdec5627fb8e8ab4f5e2cc991a6fb0ce0adfe41fe8358ea8c37ac60816d",
      "bel": "bp(MESH:\"Erythrocyte Deformability\")"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Apoptosis",
      "id": "39c21a5bf990cacd109cd022171f1f8d53f15707601351a2acf509f4f1a1c21650a3be4e5ddc8df4e09a2d236cc4cc03242239c0b4cde5940d3950792f6b9449",
      "bel": "bp(MESH:Apoptosis)"
    },
    {
      "function": "Complex",
      "namespace": "SCOMP",
      "name": "MHC Class II Complex",
      "id": "e9b776ff36c4d8ca58b6e59320acb7508ef7f98c8d39a3da2cee4d3ac2b1a6ff61672a81c537c824ce5d0f9dfc983740948e0ba17cfe91ba37376c5052d6f3cb",
      "bel": "complex(SCOMP:\"MHC Class II Complex\")"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "heme",
          "id": "719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc",
          "bel": "a(CHEBI:heme)"
        },
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate",
          "id": "719830adfd09d0e9dc001b63806cc58af6b5abbe3df66d50a75637b7461ccd38704254c6eab0edf04b2bb34515a38051bf13ee91e0e5e6870cf1a8a5930118ce",
          "bel": "a(MESH:\"ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate\")"
        }
      ],
      "id": "60af3ca63f68a0532430a0819a2e6af69c7122e58a368884ec7c1d124e11ac291bbbd3319447e15c35a2ec8b59000f864beacee079cd8168f4fb330e30ebde7b",
      "bel": "complex(a(CHEBI:heme), a(MESH:\"ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate\"))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "heme",
          "id": "719ca721f83fc39055585fbe7f31ad8173f7538a3cfa3792732de47c43a36048e922aa16d66b08e964b7d4a89e214d0d313bce30a38fe67755b9428cdec247cc",
          "bel": "a(CHEBI:heme)"
        },
        {
          "function": "Protein",
          "namespace": "MGI",
          "name": "Hpx",
          "id": "ccdc2439745a084dbbe73e6559429f702bfbdd9823ad4837b3232123b8c4a6c91ffd44740d989f368c570e462c58632040fcfa2d5e947abff06413ab3ce7ec44",
          "bel": "p(MGI:Hpx)"
        }
      ],
      "id": "a28e94760af121bf3833287a964c8f5f9e882de2e94edbb8657b283c46da1e75360b14c9031560bf441a5aef08ec3ba78e079ea29f268174dadca7b5e901eddc",
      "bel": "complex(a(CHEBI:heme), p(MGI:Hpx))"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ARG1",
      "id": "5a22e8a6a06798db189eaf7077500e65178452314b74f9cfbdf4f562f8911827e0457d43e366bef07b5a669c8397c0fb69e518ce0212738ec3faaf624286f256",
      "bel": "p(HGNC:ARG1)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CD14",
      "id": "700f409711492697b2f4eda37d847650d614903f2ce3387d7a4227f9c190d797770b6d4bfd29a68506f615747151aff24fce4648478255876b4fe11e9b83de1e",
      "bel": "p(HGNC:CD14)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CD86",
      "id": "64622ec2669c760a4eb7bb44ba0741781e19adda870f883bf7ac1399009013e84ba463a3ae783abbe92c43878bcfb74d5dbd5251323a4241d4247e83e9ba02cb",
      "bel": "p(HGNC:CD86)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FTL",
      "id": "2c6bd830baeec5034a01b8661c74c08bd453b3da90dea7dc8ae5813cb00a2a54e954fc67fa9fcd5a80f82af179e28045640c3d92d0d8261a85e9411af9426f41",
      "bel": "p(HGNC:FTL)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HBB",
      "id": "75606239f93ac271516eb110566907523dfdbf0a1937760050e049e79942bd684a190c3dd54b45444c2c5b5217192e72df697c824cbb392f90f2fa4005d9adb1",
      "bel": "p(HGNC:HBB)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HMOX1",
      "id": "c4981e9d3903b58471e749e0a1e38277c2729152c5582926243649d5c266ea44d831061cf916b7c6334634d357628b16c015a7ce07c97084f06b2c3f3cc94d5c",
      "bel": "p(HGNC:HMOX1)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HPX",
      "id": "903fb55a7cb538b12d22305b73d01f90a340e7fd5622711c4b41d1538af80cbb1ed5bc2f065f360c8bdc8d377993c9b55bd06633323591ed22f54741612c3775",
      "bel": "p(HGNC:HPX)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IL10",
      "id": "e74ff45cc5d8052e54a0597bbe401cf0982ff5d49b0040ea87c18a1c43e921e030bc2315004b4edc7eec1fe6b171b95e2437d751cef7da75c9099813845b945a",
      "bel": "p(HGNC:IL10)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IL15",
      "id": "246183385e92b28aaf590e01131f94245a0ab36e0289d0f65b9f975c872a20ce1ec9d7cc1c46a5990f66a48927e4409d71417385eaa37fddf0607b710aa6b5f4",
      "bel": "p(HGNC:IL15)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IL1B",
      "id": "bd7736973dc00dadc09dff75214ff05344d2e9b6dfbc09a364f08b7cae84142149292551bd60d5addd6130e971c2ccd4c73b963ad918ad9b0a418b94e5a30cfd",
      "bel": "p(HGNC:IL1B)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IL6",
      "id": "51885c84a128c79b3473fbff464c7f04886821c78a7b0097d2e9fa942742f7586bf06c4fcce3776b98a284d6d0f0c669f1e6b0a029047df3f9f1549abf57ecba",
      "bel": "p(HGNC:IL6)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MRC1",
      "id": "84393d517fa323c281bb45c80e33ec27a16232e352d140a908b01d0d3a019f7b9306d7267d4e4b135cce96b6d189c58f10f95413b77522dfb154f31ca681af97",
      "bel": "p(HGNC:MRC1)"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TNF",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d",
      "bel": "p(HGNC:TNF)"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "Peptidase M10A",
      "id": "2c12cef498a8ec6e5b1a55fc9e4d86529c6cea74b90c269aed5f16013ce086ba237eda6cb51f9209734e080e4ceb67456b7d73be529f9a5fd28049a9c5edec28",
      "bel": "p(INTERPRO:\"Peptidase M10A\")"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Acta2",
      "id": "ad1ea0150adc3095c83f4345a60e5f38fa13d6559b29c077a984bcf15bddbfd95f147bbff54248239b0c0bb1e1cdf54465e6ce557fef461859b59a595f290590",
      "bel": "p(MGI:Acta2)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Ccl2",
      "id": "e744948f04b63bd323a2163de4a23ce58922dc3d86a473a27014613c3c439ac1ad191bb793ba0458db3884be5b4bfeffa2def6c778776aae1efdf5cfa0c976af",
      "bel": "p(MGI:Ccl2)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Csf1",
      "id": "ac8c8a7603e97811a79987d3d2096aae69cc3c799823890bb6c6edb2334bf0dd79ecc6add7975e2b406fb08b168aad9f15f6953eada1aff109725dcb3bb99084",
      "bel": "p(MGI:Csf1)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Hpx",
      "id": "ccdc2439745a084dbbe73e6559429f702bfbdd9823ad4837b3232123b8c4a6c91ffd44740d989f368c570e462c58632040fcfa2d5e947abff06413ab3ce7ec44",
      "bel": "p(MGI:Hpx)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mmp12",
      "id": "58a6720cc15bf3eb9858e4270b454e8ee110486af4dfa3ae6b81222ab8052c40e8d29338cace11303fe37626f867538f8a5c6988f244d77f90b4b2884492834a",
      "bel": "p(MGI:Mmp12)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mmp13",
      "id": "a57db54674c0cbaf7938f6ec3b872d731309d9f2a9aef18c38a509ce713ab8e33f9214e8d15a7502fd4ac200cede6abd088e7e9a0a3333c8c2f9ad6a94466037",
      "bel": "p(MGI:Mmp13)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mmp9",
      "id": "112065a8e85d9de5bdf8b93107f2a0c7e954898983ab49429b480bf0a9a277c00fa0fa648d65e0390bb9c851a0345b9f5175c4e01c623a99e24be933948c251e",
      "bel": "p(MGI:Mmp9)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Syp",
      "id": "81f5125d4b52aac9a857be32b63ec0cfb4206764335f8942e31d07bc0d579e8dab81cc419d387f2d6d3913d6b219d530e68d5199d0106174a91f1824a212a736",
      "bel": "p(MGI:Syp)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Tgfb1",
      "id": "0be7ba21068ae648529a99e9f3db433a861e5265e4ad3f1248d540a4dded0282c5eaa3478caa166e0de878a4dcb82ff7e9ef3e8be5a191c42f39ed273407224c",
      "bel": "p(MGI:Tgfb1)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Timp2",
      "id": "cf4d3174297da1ce5bc520a699549852917cbc2c89f902b0faccbadd702814b7eebfb3d8d7d0289632a337e6c6fe0ed968be66b70719f46ec964944e973ef2a3",
      "bel": "p(MGI:Timp2)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Tlr4",
      "id": "3ed0d387c1898f210a01623e8881069555cd5a7ab7389c889536d0ba941377a7debe9b7dc290afb4645e225eb41c3bedf6b78126afaafafd605bc1500b1a39c5",
      "bel": "p(MGI:Tlr4)"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Tnf",
      "id": "a45cfec2fa122ac50a93a261bc8a06b78b1756617089bb7c55634a6f53f49a60f04f79884235d0da17620eedecf0a8422cc773f07b0dcabf7aad98cf3ebf0b72",
      "bel": "p(MGI:Tnf)"
    },
    {
      "function": "Protein",
      "namespace": "PFAM",
      "name": "NO_synthase",
      "id": "180c3fb6b5fe7ad7c2290ab1b7ac8b7feb1149b79b22c121332c5d4205021b92473e35cc012c08efd95244dc95bf06e4ddc09ea55218ad2cc67e96b958eb8c0f",
      "bel": "p(PFAM:\"NO_synthase\")"
    },
    {
      "function": "Protein",
      "namespace": "PFAM",
      "name": "FPN1",
      "id": "65d05214e3dc914784efe77a883827bc480d6869719a820b33fe7862aafbb3de5f622c4152a78d6e7734356c484b6f1a414215f8119a16ec8a72edd2fa1ed1d1",
      "bel": "p(PFAM:FPN1)"
    },
    {
      "function": "Protein",
      "namespace": "PFAM",
      "name": "PDGF",
      "id": "0ab9f138cad65537b243f239e991061a50d2ce8d042889e14f1433e624557dfd58e975f92fab98c45711bc2cbc04b7a8e35108a6efc3ed0bec2f4bfac01be515",
      "bel": "p(PFAM:PDGF)"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Fibrosis",
      "id": "0b1c5f160d153dd4c47fbf2e5fb19c565dd3052f4683c97f0ae5cedde1fe663502b22f7c5871409f17f0b9f28cf0a76fecdd7f5a55aa89be50a95a4775225db0",
      "bel": "path(MESH:Fibrosis)"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Inflammation",
      "id": "3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e",
      "bel": "path(MESH:Inflammation)"
    },
    {
      "function": "RNA",
      "namespace": "HGNC",
      "name": "HMOX1",
      "id": "444b069d697568bd9a0175d47f676686fc629c78191bddf707a0f16aae36fd7cc18a6cd2bc26801fd958893e7639f01b2b8419fe10ffea5a851373c49260f3e7",
      "bel": "r(HGNC:HMOX1)"
    },
    {
      "function": "RNA",
      "namespace": "HGNC",
      "name": "IL6",
      "id": "a104b7a886d99f72ef09375dd3a602c077c0b0b883a3af2f9187638d8f109dde5eff05be26eb1c5636c3d281aa9db660ea9039534f51bdebfe2185d8979ebbac",
      "bel": "r(HGNC:IL6)"
    }
  ],
  "links": [
    {
      "line": 96,
      "relation": "positiveCorrelation",
      "evidence": "Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 12,
      "target": 21,
      "key": "df3ffa89762be101998a8a3f0f701e23cbd0b9d8e85938dc9eba522ebcc5dc7b8794819806c180d32a0965b37a76fde6886a0fca82ef49e50aa4cc7946b95db0"
    },
    {
      "line": 97,
      "relation": "positiveCorrelation",
      "evidence": "Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 12,
      "target": 5,
      "key": "294660bf8b1ecf3cf924ad030745b908b65a82d16a4dbcbe2b27479aa5e749bb8be4fb21cdf5bce41b1c2f2e64706989f3e798d939a734c25dd40c6ece1eba10"
    },
    {
      "line": 96,
      "relation": "positiveCorrelation",
      "evidence": "Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 21,
      "target": 12,
      "key": "6dcd770c2faa86079bb84cfd7265ef41412f76069c56b5c7c504e46c167d9c8dda7148370f5f39ac41012f9f851be106f77aead05eb977b2e1d5bc5f4176a2c5"
    },
    {
      "line": 338,
      "relation": "increases",
      "evidence": "This is the case in a mouse model of SCD, which is hallmarked by hemolysis, increased circulating Hb/heme, and low levels of Hp and Hx and shows elevated hepatic macrophage iron levels and M1 polarization.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 21,
      "target": 7,
      "key": "368c6b366892a15cb97e4f5f150322df88e5a606e4b4156176526f1ff530e300e64e822132da11b26cc37e3527f456a45d5a8319d7285b8318278dce009f3315"
    },
    {
      "line": 97,
      "relation": "positiveCorrelation",
      "evidence": "Sickle cell disease (SCD) and malaria are paradigmatic hemolytic disorders, in which alteration in the structure of red blood cells (RBCs) leads to the release of Hb and heme into the circulation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 5,
      "target": 12,
      "key": "2571627d8d8f36af9975183d53377e786d1131d3bd3a0ba0764bf2abd211d6a4f59902ff2df0c79478e59aea3cbc25a169ad393e0db0e38749141bf5183b52d7"
    },
    {
      "line": 103,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 5,
      "target": 3,
      "key": "19f40cdec50ad026402c9c524654bc83404e4612917294c5b2c8c57d4155a410b176a99145022b991c73ad4c22eaa5c5bbc381115bf2c640578c3696ae916f5b"
    },
    {
      "line": 104,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 5,
      "target": 1,
      "key": "d394d54b0588fcf526a3548b3e748523faaf8c2afbaddf732bd48f81480c85a6ad5d4aa6ee4b31f140b69907aec6800bd9db749350af5ea22da7a00bb4d544bd"
    },
    {
      "line": 105,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 5,
      "target": 4,
      "key": "6c7632a87c84500e81d9080264e574f3efc6030d42784cb1311a599d064076db77e76fc912fb654216418ff3131b43101664312e52df88081e6ac7b9fe014dc3"
    },
    {
      "line": 136,
      "relation": "increases",
      "evidence": "Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 48,
      "key": "d5ee0dd053f64e0ee047b4cf669930d4c6aff8568b89e6567a75b17724b2f1274d6590d3b8523b63d42cc7cb7718a61204d070b4533bf32f5bcc25fa04935fa8"
    },
    {
      "line": 137,
      "relation": "increases",
      "evidence": "Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 22,
      "key": "eac48ff57132abc207e7e9047469867324bdc8b35a79d0457623d888df8a84ca9315c97813426cb21faa6248b3a34cb28b8b0605aabed744badf76de7a84e6e0"
    },
    {
      "line": 138,
      "relation": "increases",
      "evidence": "Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 20,
      "key": "b1e03d3b30297a154fc660e8aeaddbd6f25a6030842196aa654ff90cc9ef07ced9f7838abb8356fc3d3f051d9c157a5ac7759c327a74af0d88294ad19d3abd98"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 44,
      "key": "84f61bb48eb1be7c678beca668d1bac259fb54083e83ee8bbfb42e6d9ebf2b39b91bee9627f2d67cc23651f532fb6e92411f1311edec75da76beb6391094903b"
    },
    {
      "line": 140,
      "relation": "increases",
      "evidence": "Consistently, CD11b cells (granulocytes and monocytes) and iron-rich cells (macrophages) isolated from heme-treated Hx-null mice show a higher heme content and increased mRNA and protein expression of HO-1, Lferritin, and Fpn (Figure 1B-G) and elevated mRNA levels of the proinflammatory cytokine IL-6 ( Figure 1H).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 49,
      "key": "033ae89f54c3084fb7656e6981609321512714f53bcae78453c41b9d59516a4fce66c8f291fe0dab8f6e8cdb3f44344adcb5d5a97e0839354510d7f071077ce2"
    },
    {
      "line": 146,
      "relation": "increases",
      "evidence": "In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 8,
      "key": "481a54403f785bdbd2bab7f521f817fbaad470d2cf3b217eceb9be2654d243dd741b73f2c5343cd903cb2c26b3f62d512cd9002b682f8a46c785b45b4c2ef363"
    },
    {
      "line": 147,
      "relation": "increases",
      "evidence": "In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 27,
      "key": "b7a9a2cd5598e57bf4f138922c65ea13740d122f3001a3c58d634373ba0c8a3ddee59680d65cb634d7989f02bab6e9d902324913c19769bf8d4ffbd916eb55d8"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 27,
      "key": "4e5f165e02e9c9b5fccf83ebefeedeb6e36887e7835ff653e5ce94f9b0264e2212b400e6709ed5b888b7563419be86571a4ceb23dc20ec31053dfb85c8deac98"
    },
    {
      "line": 148,
      "relation": "increases",
      "evidence": "In addition, we observed increased ROS production ( Figure 2I; supplemental Figure 2), as well as an enhanced expression of IL-6 and TNFα in cells treated with heme-albumin compared with heme-Hx (Figure 2J-K).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 5,
      "target": 29,
      "key": "252577d306a047ad74c4802c17732c6e3a5781f2b73d79f1e9c719233602f9dde1320e73e3828a3939e345fd36e3f6b2db21c945002ed713122b739d83d993ec"
    },
    {
      "line": 163,
      "relation": "increases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 14,
      "key": "569e067fb31d4f32c61d7beee2da45473cabbd38628be6675add936f69a1daafa6e8cc4e19a8334d0d3fc50afaafc43c134c4995c59b7ce27fc1fda74f939dd8"
    },
    {
      "line": 186,
      "relation": "increases",
      "evidence": "Importantly, 15 hours after heme injection, hepatic macrophages showed iron deposition (data not shown) and an increased expression of the M1 markers MHCII and CD86 and reduced levels of the M2 markers CD206 and Arginase-1 compared with nontreated mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 14,
      "key": "8f1cbefd77611c82735e5004950033a44cf9284624db99dac5805972f60eed949b9dd96adbdde9b8cbfcde95fdd3d91589c8d0fdf12fd9c51dcfd03204452712"
    },
    {
      "line": 164,
      "relation": "increases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 19,
      "key": "5f9064298cf3841e7295c0283ae2dba0aead3e6245039017db117e029dcb86b91e098512e15c2d53cb5d787f9a01e7b19c7f356fe1a7488acf1b5dc3394076ae"
    },
    {
      "line": 187,
      "relation": "increases",
      "evidence": "Importantly, 15 hours after heme injection, hepatic macrophages showed iron deposition (data not shown) and an increased expression of the M1 markers MHCII and CD86 and reduced levels of the M2 markers CD206 and Arginase-1 compared with nontreated mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 19,
      "key": "8dc1eefa734f4c4b2ef28ac7ed186bbc462ab0bb76222fcf8adaf55c3b8d5085ccc1e91ad8eece667aa7a73ca91c3d50cec80a17c53cdc6d97f5bcd9bc2b597b"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "Likewise, splenic macrophages from heme-treated mice show increased expression of CD86 and reduced levels of CD206 and Arginase-1 (Figure 3D).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 19,
      "key": "df2df90f9e490fe553506c99111ef33ed6fc11637d77bfebdd69a34d76a31357d02557a99acedaa4f7d1e3580471fc0ca26b44dc9bab5cf86fc1b3d54404f5db"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 18,
      "key": "c44ef0e23276596c3cd066e98183b617e2b1e6e9b47d05c9744c462e42a647550f027869d990f5e2af3b85a65a4a6286dc8d05294778f3419cf7a5cc98315ddf"
    },
    {
      "line": 167,
      "relation": "increases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 26,
      "key": "24c9b73e83f204e48f4ff4fbe19847cabde20b2f2f769d538d36eec221aed6daa9474ae353fa36f4e9b815a0f8d0004d908320350cd84f8316c6827d48087c10"
    },
    {
      "line": 169,
      "relation": "decreases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 28,
      "key": "eae2fb4694ed24f57411bca6cebf499bdbbae1beaaee2f5a16a52d406b89d42d54c9d994a70b6d1bb20683a5587b344d08e9fa2b90fb84d85b3211f277fa6581"
    },
    {
      "line": 188,
      "relation": "decreases",
      "evidence": "Importantly, 15 hours after heme injection, hepatic macrophages showed iron deposition (data not shown) and an increased expression of the M1 markers MHCII and CD86 and reduced levels of the M2 markers CD206 and Arginase-1 compared with nontreated mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 28,
      "key": "6e780463091b0b63df9e1ee5c98f9f8ba021ff9ab53d9275b76b9048c101a24e4fe092f845f1fc683dfd2ae336740f6b312989ffb512072593d2b1d1d54aebe9"
    },
    {
      "line": 197,
      "relation": "decreases",
      "evidence": "Likewise, splenic macrophages from heme-treated mice show increased expression of CD86 and reduced levels of CD206 and Arginase-1 (Figure 3D).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 28,
      "key": "cd6994dabf2514b31a124b56ef273c420b2d8190db9d44c0519271bb8252c7313140d74ea8c0fbf056647865505ce0e487332142be1c9365382486eb043ab0fe"
    },
    {
      "line": 170,
      "relation": "decreases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 24,
      "key": "5addee7dd55259a2e9ad5956436c350850b5a7646ffcee3254591c1cfe43df58a34527114ff5ad828a0ad9dfd04b20e4f7fce08f510fb64c8f383f78c7f787e1"
    },
    {
      "line": 171,
      "relation": "decreases",
      "evidence": "Likewise, heme and FeNTA treatment causes the induction of the M1 markers MHCII, CD86, CD14, TNFα, IL-6, and IL1β and a decrease in the M2 markers CD206, IL-10, and Arginase-1 (the last with FeNTA only) in M0 BMDMs (Figure 3A; supplemental Figures 5, 6A, and 7).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 5,
      "target": 17,
      "key": "9c44fd233577016271eec5c6e73619677009d41e9cf2e84da49c6cc7aef0aec339199f39ea23427abf3845387b9f1ee12762571fbbaf0fbea0dde0284236f899"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "Importantly, 15 hours after heme injection, hepatic macrophages showed iron deposition (data not shown) and an increased expression of the M1 markers MHCII and CD86 and reduced levels of the M2 markers CD206 and Arginase-1 compared with nontreated mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 17,
      "key": "2ed517e4645cc8dece404002064b631e3eabf18a245f5bdf62ce5e6cc04dc58d6d00b9afaad0b673263e54b7439d33104b3f0a4fdec2c3e220377215069260fd"
    },
    {
      "line": 198,
      "relation": "decreases",
      "evidence": "Likewise, splenic macrophages from heme-treated mice show increased expression of CD86 and reduced levels of CD206 and Arginase-1 (Figure 3D).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 17,
      "key": "a4a967b0f90698bebf9e28918fba194dd16ebf9a3aa25aa0535d8036f778fcfe4ba95f46af0ce1c333ebdb09cd5b8687a9e0a8c2c0d3441c1c906179fac18538"
    },
    {
      "line": 337,
      "relation": "increases",
      "evidence": "This is the case in a mouse model of SCD, which is hallmarked by hemolysis, increased circulating Hb/heme, and low levels of Hp and Hx and shows elevated hepatic macrophage iron levels and M1 polarization.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 7,
      "key": "df11ad34e94c5611cdcb36f9e84e59a1aadbccb48e7afb52ea30752097d87d29506dfb99a0cfe68842a3d8a8d9de9b278958f46cc0edfcbb505ff8fd3e79f795"
    },
    {
      "line": 343,
      "relation": "increases",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 7,
      "key": "e5f43d0e4c2bdfe694f5cb75d3e25b4d88a86fb83d6948b29798ef5b54cc9123c7d72ba4033ed20bf8c73b5df69b8ce5b4ab0852dab8f08360f5fea70a9be349"
    },
    {
      "line": 353,
      "relation": "increases",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 5,
      "target": 7,
      "key": "5919e84277696a46b48ca2e2f32eb7547cb7dfd9be4069c0cc4112fa0d18d383dfecd0f87d6913006bab1892b48eeb2f6ae8971e03a477981b6f30b7467e4132"
    },
    {
      "line": 103,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 3,
      "target": 5,
      "key": "5d9f5da6e48f99e7d74a12889f6acfdb01f5dbb464504ac7d5aa17ea472566447ab4af1540a8348279ffd02317d1ef953d8cbbd9f769e50f310fe3689dc93bc7"
    },
    {
      "line": 178,
      "relation": "positiveCorrelation",
      "evidence": "Importantly, protoporphyrin did not induce TNFα, suggesting a critical proinflammatory role for iron within the heme moiety (supplemental Figure 8).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 3,
      "target": 11,
      "key": "e91b60f937013c03bc0c62151b6f9d7fb33a732d808bab3254b6159bd6ccee62effdb0e307b323f2f7f311fb74bfc18c23d82bf27b1bc3f882811a2201e24101"
    },
    {
      "line": 233,
      "relation": "positiveCorrelation",
      "evidence": "Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 3,
      "target": 7,
      "key": "71c909fe0d891dd8fb558f4fee3c53dca95ea4e2e396bad57a0f7969a5b7fb425d126f4d29f4a27927f6b6e2e2142f7feede9761f8aeadfa1808a540bf85075c"
    },
    {
      "line": 104,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 1,
      "target": 5,
      "key": "84347dabe0fcd3fba2161605eea5193cef9687d80d3e2974186c51cd41a63daf465308b7b5753396d1f6e2682d37a1efca098dc3525ef2de256d08f8398f56c6"
    },
    {
      "line": 105,
      "relation": "positiveCorrelation",
      "evidence": "Within cells, heme is catabolized by the activity of heme oxygenases (inducible HO-1 and constitutive HO-2) into iron, carbon monoxide, and biliverdin.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 4,
      "target": 5,
      "key": "4fdc8adec0cfaebac447e82cfbacf31670c85ac83f7751c602256d832acd167b38462b88d49ac5dd48479b9db0c31034b0fb2ee6f12898e91a843db92e58e397"
    },
    {
      "line": 112,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 10,
      "target": 25,
      "key": "f804484e75ba47b8db2c7980df558c64f5e1a15bff9d67ed525c3bbe853f3d07c86f44a39bf88aa8bff0a5c3e81f78e5d9f6e59a9f31fe9d5086139152d3e574"
    },
    {
      "line": 113,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 10,
      "target": 29,
      "key": "c7ecd932be04932ea120e79b6a0974baf033da10f7cc030094160d65cbdaee7871a08d7087e641c0a7f170af68be16f9567b3123e31f56aa7cdbb49ffb135644"
    },
    {
      "line": 114,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 10,
      "target": 26,
      "key": "02a5eb7afb5e1225ee9be38adbd0152c6b7f509ada8ffc443a0cd10d4a03b0c0c985aebaf60f4d41c41b8f953dab828eceaad1428fc059ebc6e536dadb5f4df0"
    },
    {
      "line": 112,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 25,
      "target": 10,
      "key": "7d64c30512885ec1005fb2b8629151db6deb03fca888f5a3d7e56e668ec982ee12964e75b76d3e3688e41644baf5bc8f2433dc170790b228bb16a3b9619b46ec"
    },
    {
      "line": 113,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 29,
      "target": 10,
      "key": "63ccffe22f6d5ecf2bd4f6957561cff838a488645187b1b2a05b7ff8c93554f50a454afb2fb2a7e8005c517c500dd827b0e02b38ea81fbebfb28044ba4be7ca4"
    },
    {
      "line": 114,
      "relation": "positiveCorrelation",
      "evidence": "For example, monocytes from SCD patients show an enhanced state of activation, with increased expression of interleukin (IL)-15 and production of TNFα and IL-1β.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Introduction": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        }
      },
      "source": 26,
      "target": 10,
      "key": "49c205b96e695beca50ee21432c4935e76d1eb4f173bebc48ff2d5b0767a9e585bd4e88f0584d23f18104f467c6543d1d946c03a1926a7dd17dbb8bda6aa6332"
    },
    {
      "line": 128,
      "relation": "decreases",
      "evidence": "Recently, we demonstrated that Hx controls hepatic heme uptake and thus limits heme accumulation in extrahepatic tissues, such as the vessel wall and the heart, preventing heme-induced toxicity and tissue injury.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        }
      },
      "source": 23,
      "target": 5,
      "key": "5f580240c76eb38b5bbce00684cf1a82c6c24d2be5ec8f623ff0f172745dc18735a76c4c01106862a47cf83eda782ee9ae17b53200a427137cb5c71bb5a2d8c3"
    },
    {
      "line": 154,
      "relation": "decreases",
      "evidence": "Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 23,
      "target": 5,
      "key": "b8d852403687d91d829fe2208c74460b98115d58e9bc1f00f1a4574867d936dc5a98ca4bd2ddb0277138be251b9f06acb7fe09e87e9000dc20f6f6db67e435d3"
    },
    {
      "line": 155,
      "relation": "decreases",
      "evidence": "Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 23,
      "target": 8,
      "key": "d719a4b2921fed8730f3425c0a96a1c0785ffa13ad920cddbcee6068b0fe74afd25c9cc60106ae57952bb1fe547c82de89d9c0130152c7cd246daf8858fdb783"
    },
    {
      "line": 156,
      "relation": "decreases",
      "evidence": "Taken together, these data demonstrate that Hx limits macrophage heme overload and prevents the prooxidant and proinflammatory effects triggered by heme in cellular assays and in vivo.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 23,
      "target": 11,
      "key": "58d8e84499ba434e0efbf32314cb2b401c3ea2211670fae6ed651696184366c681910335d97f1a278f89ca6c7d57e0739cf2a2a0b7d8806828dbbb1b9a64e75e"
    },
    {
      "line": 259,
      "relation": "negativeCorrelation",
      "evidence": "Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 7,
      "key": "98f5bef2068cfb0f4df9c7d578d40a8d91914693f90e6aeef9354fb723949281d2a5535ee7741fd764e8f3cd84c7e77f47969383f82f1e003fbe79916bc5e75b"
    },
    {
      "line": 267,
      "relation": "decreases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 14,
      "key": "d6139f35bc3d4e05918f0b50e9350758c51edc09e9f45e4761931353a459db941240da27f25b4ceaae6367a9e8de29f5171d3f5de029f331a0eb433fcbcccc20"
    },
    {
      "line": 268,
      "relation": "decreases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 19,
      "key": "cee86cb6798544c09e57b8906162d12a2140952f2edf2095604ae9d01ffccea2da763fa963d41549ef79b2f4bfae8cddc75e2135093242a4d4bca070b67643a9"
    },
    {
      "line": 269,
      "relation": "decreases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 18,
      "key": "8fe0583ea341c4a81947d8f820015b7853cbc634ef90a657f21177489d7f5e83676cdf958e448e83f5f998b4662c373545cc9e2a9aa5bd9b80fdbb0fc98c7ded"
    },
    {
      "line": 270,
      "relation": "decreases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 29,
      "key": "3a32830e90a9a8d53c362ed598a584f9babe06a491c6960ba44cda6b9cd8f2e2c149b6271c98b2553deb7469c942a8056aeb463e2a721d0ec78a88a09175a939"
    },
    {
      "line": 271,
      "relation": "increases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 28,
      "key": "8e4e0b8a153e1f5ddfea4a11d1d8b6a274e756d4326bbe5ea024b3c14a8954707ab8d56cfdea65cb5a3915d98827f96dd2c0bd9b15ff9069114b519aa392d7b0"
    },
    {
      "line": 272,
      "relation": "increases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 17,
      "key": "74f67eeb811b558bcc4b06f25dd729b7da212ecda236cfbb401c3e6fda85f76f4ac137eb6ea115250cacdea23b2eaf870183417d27633d9fd943a28c599e7c9d"
    },
    {
      "line": 273,
      "relation": "increases",
      "evidence": "In addition, Hx and DFO prevented the heme- and ironmediated induction of the M1 markers MHCII, CD86, CD14, and TNFα and the decrease of some M2 markers, such as CD206, IL-10, and Arginase-1 (the last for FeNTA only) in M0 BMDMs (Figure 6A; supplemental Figure 15A).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 23,
      "target": 24,
      "key": "2d2c2aebf74f0ab2e30e8d878d42e83379cfcd4f5a7d00cd420edaf53dbda4cbe155264acd65487201f5c1a114c8ba7118c103fb67f1fa426fd16f32e3faa52c"
    },
    {
      "line": 346,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 8,
      "target": 34,
      "key": "6014c9d4a2c99a64e2b940238701aaee03e12c9e002e85d9d3bc15fea7edaf39e656424245c9d566642e49439fcbf8b46f9d883720bcd30210f959ddda0fe7fe"
    },
    {
      "line": 178,
      "relation": "positiveCorrelation",
      "evidence": "Importantly, protoporphyrin did not induce TNFα, suggesting a critical proinflammatory role for iron within the heme moiety (supplemental Figure 8).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 11,
      "target": 3,
      "key": "e43282ed455a88fa0609e6f04cfbb0360f53299222e95aeed72fb1fa638565f67d5c11ddfee81cadad6309926adc3dffa98ed5149696efc9c0a5f7bae3ba9c91"
    },
    {
      "line": 318,
      "relation": "negativeCorrelation",
      "evidence": "Taken together, these data suggest that Hx administration decreases heme-driven proinflammatory activation of macrophages.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 11,
      "target": 34,
      "key": "6ed3ffdefb139ede99e696ae287dbf869b814de9887bc490718ca38358fdff609c9cc4ba5600baa62d58129477620443e8100a8c6d5adc469fdc1dfdcd113adc"
    },
    {
      "line": 324,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 11,
      "target": 34,
      "key": "1d1a9052b1ff23cef353d868bc75a5a15c45378c11301090ada67326ba40dec2ec87fa447b917981aa2307b1c143af202392edd76a6cc9a3d78f7aa1725f5e40"
    },
    {
      "line": 357,
      "relation": "negativeCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 11,
      "target": 34,
      "key": "209df6fd91ae5e34d96f400d02fe4ed4056141980d1621a21f9a85f9c06d0b73fe06036f41835437cca3eb0cfff5096aaacb75f8b229105ff6382b7b65f3602d"
    },
    {
      "line": 354,
      "relation": "positiveCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 11,
      "target": 7,
      "key": "9805243ca422dda62f80197b647cd9e00edc681bccc96691509a56f2780bddd379514104c677847d81d1a887aa7bf45b51f506a272fcb5205d271900af1b96d5"
    },
    {
      "line": 355,
      "relation": "positiveCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 11,
      "target": 47,
      "key": "1c9dd3b358f430d679535b89c5f7dde96ba3bc32a7a46f82c1bba7fe88a69473b799d869cb63b81dc94f7d7dc935dad7773e3f3f292a762fd165f4fd3a74ba56"
    },
    {
      "line": 253,
      "relation": "positiveCorrelation",
      "evidence": "In hepatic macrophages, TAK-242 also diminished heme-driven induction of IL-6 and TNFα and NAC partially recovered CD206 downregulation ( Figure 5B-C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 28,
      "target": 0,
      "key": "d494089c8f70afee2e380b732d49ad3e34b58cb444cb2a76c5f0a09dd16dd217ac8a28034f87238fcaacf997bae9b24322641f04dd5f48969af5d5ce2a60c12e"
    },
    {
      "line": 177,
      "relation": "causesNoChange",
      "evidence": "Importantly, protoporphyrin did not induce TNFα, suggesting a critical proinflammatory role for iron within the heme moiety (supplemental Figure 8).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        }
      },
      "source": 6,
      "target": 29,
      "key": "e23ca61a0b95733310e9c0ca7a2d9965fb78c4bd4ea92538ade5c5787cd9da4aa9fe755fcbbace6ce161bff28751b838ab59a88c09cd2083bf7426053ae3e4b6"
    },
    {
      "relation": "hasComponent",
      "source": 15,
      "target": 5,
      "key": "d3eda27a76b6dc325b5f653aefd604add0075745168f1e3f6045465116d9c104a0d7085a3ebc7294944a74265a33db8119625e139e17f9f455295705d6fc3bce"
    },
    {
      "relation": "hasComponent",
      "source": 15,
      "target": 9,
      "key": "ba5635ed49cac98eb91e990410a167d643264d8fdf7632e96a47242d1a27f213dcd2d0ebced65b45b3da87a2c343c2c535e87f6dc8bd3b32765cc3ade7c83984"
    },
    {
      "line": 205,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 14,
      "key": "e8bd30d4510ba6c19136fe3387f7b970b3b15d1f24891c6bee329208ac2a316801273b7466da35b3219c93f81c6b6ec29abaf574e82073ecb4c3fef852d02c44"
    },
    {
      "line": 206,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 18,
      "key": "f6638038ffd6ddeeed373fc312cfe50cc5e87eae217b808bb1e32c52861b798350cb395d1f45188b65f790ba3840ce2c5992aed0db9e2c9d084ea38e8388baed"
    },
    {
      "line": 207,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 29,
      "key": "5da1806e99058ff0e931dd407e5343c587cb54d0bce5f56162371a1ef1e57446f5fcb5e91b915c6fd72075377ef165a475845fe9a1dd03dbe57ebdbd6f956619"
    },
    {
      "line": 208,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 27,
      "key": "02cf9fcf691719eb1a181825cd525f1dee686318900246f1e996b412927d1d14a4eededfa8b0f110715484166a72159e3ddcab1af7d214f308b944ee8df2e8c2"
    },
    {
      "line": 209,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 26,
      "key": "e5e57710c86c6453dcf950925967b4a38c8f7bff3d14ebb8b6f6f4b485670e16b549e163e653c181396da82f444f04e374c774ace5dc832cacb952db1a2e08e6"
    },
    {
      "line": 210,
      "relation": "decreases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 19,
      "key": "44e4c8e9497086077fb938bcc8d2bf56f45f0346d71dbed2ac591468954879d75ebe625371612c530dd51fdd091e82019a017b7b56b654f4e17f38fdd72d03da"
    },
    {
      "line": 212,
      "relation": "increases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 28,
      "key": "79da23ae8ed7a38a8e98e1ef8fabe8fc1b74acd8cbadbd9108c3784ba38139c1d4c5c976430c01f42fba90124abda444b88483d709f74203474e07cec5dc0a7a"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Cotreatment of M0 BMDMs with heme and TAK-242 attenuated the increase of the M1 markers MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and the decrease of the M2 marker CD206, IL-10, and Ym1 in comparison with heme treatment alone ( Figure 4A; supplemental Figures 5 and 12).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 15,
      "target": 24,
      "key": "ca89013ff2df722f72ed4ce50f4f57790b18fa0b904f9ce75d9e2473929acebec62c4c1567b4547eb7ff68c80b01c37bd6ee681fc656ca69bfd05fe070828e42"
    },
    {
      "line": 242,
      "relation": "decreases",
      "evidence": "In hepatic and splenic macrophages, cotreatment with NAC or TAK-242 reduced the heme-induced upregulation of the M1 markers MHCII and CD86 and attenuated inducible nitric oxide synthase (iNOS) expression.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 9,
      "target": 14,
      "key": "ac7770c3357b63c73b1e66e795693aba18c3d120782d91f9310941188199cd8029ee8c8998accacec1a1802317eadc9e0e2d22af6082aa0b717ade2ddfaa7c7e"
    },
    {
      "line": 243,
      "relation": "decreases",
      "evidence": "In hepatic and splenic macrophages, cotreatment with NAC or TAK-242 reduced the heme-induced upregulation of the M1 markers MHCII and CD86 and attenuated inducible nitric oxide synthase (iNOS) expression.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 9,
      "target": 19,
      "key": "3695bd396b5363fcc10bf578b3eb305bef3a346a151f3c9c772e126f557ed7194ec8bf9b2f78c47f447942bb6f6f365ec7ca16d4903966a998d01051e277b113"
    },
    {
      "line": 244,
      "relation": "decreases",
      "evidence": "In hepatic and splenic macrophages, cotreatment with NAC or TAK-242 reduced the heme-induced upregulation of the M1 markers MHCII and CD86 and attenuated inducible nitric oxide synthase (iNOS) expression.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 9,
      "target": 43,
      "key": "4923c10f67682bd38073ee115f61b623156b198c8b098f5c1b146548010cf17c08488a818ef188a3e92975c205f07f99cfea6dc21e1cc47b6d03c7f5bc69acd4"
    },
    {
      "line": 251,
      "relation": "decreases",
      "evidence": "In hepatic macrophages, TAK-242 also diminished heme-driven induction of IL-6 and TNFα and NAC partially recovered CD206 downregulation ( Figure 5B-C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 9,
      "target": 27,
      "key": "1e47a7f57ae37c57207a413b5a99252703606d60574a982aa0189ec1855ba73e3783ad4c71c93be1fad61a541d34101d0cc5f9ab90c1a8f72a4a5c9cdec87377"
    },
    {
      "line": 252,
      "relation": "decreases",
      "evidence": "In hepatic macrophages, TAK-242 also diminished heme-driven induction of IL-6 and TNFα and NAC partially recovered CD206 downregulation ( Figure 5B-C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 9,
      "target": 29,
      "key": "6e7ed8de410afd4d6b8ff3451372117b5648e955919f3b69b6876a5e0858bd1fe902725d548ccdaab8de103071c680e4131206c6c00fbae70e784a5662b60d67"
    },
    {
      "line": 219,
      "relation": "decreases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 14,
      "key": "e9df312f321e8e15335a8024c7c90486cac3c26c4c0ab104de92fb40398b2f538bc354d4760651ca394f232934c259432c1d4ba568c74ea8aa8b1182d36cfef8"
    },
    {
      "line": 220,
      "relation": "decreases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 18,
      "key": "80579f9b6ec9e5c123757457c719a74ae199b68c6ef030cd49c3266ee7ba472f721099574a5597c1da52b0ae85248b84f0cf7686f2549ea8de8e7255561fba78"
    },
    {
      "line": 221,
      "relation": "decreases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 29,
      "key": "5946a89779767e3c89591b38aca3a0125e3530b23bf68a38eefa3f58ccd085adc71deed4f2a75731fa605d0d0afee20af6dc815a881b138bde93c19e62db62e9"
    },
    {
      "line": 222,
      "relation": "decreases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 27,
      "key": "9442f9a1997e8cd33d6e91e37b75d6d0387c1e7fbb54efce5c54d190c5621d2c143082f4b6989bd3e74d4d3e2b92f65c7370fea9e5facdace7a488efa3e3863d"
    },
    {
      "line": 223,
      "relation": "decreases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 19,
      "key": "002c4c66e1b7de9701714860acbe73f8a1dede1b2011b2230e7e20dbd437aac7365142a7de937ed612f045ae5be2d0b7aa8b80c761a8caeb5008dfa66edf7679"
    },
    {
      "line": 224,
      "relation": "increases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 28,
      "key": "29139777b59490b112836adfe6476c98cc75ce25edcdd20419b2141422cd2d51acb0400dad127d56004a545aef1708b105f4e79af6a3ff80d20cee80cfbab423"
    },
    {
      "line": 253,
      "relation": "positiveCorrelation",
      "evidence": "In hepatic macrophages, TAK-242 also diminished heme-driven induction of IL-6 and TNFα and NAC partially recovered CD206 downregulation ( Figure 5B-C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 28,
      "key": "4db5393a5e0b26621c75eb2fd53a8645b1a64067441d5d9436de6dcad18cef3e3b5d28441af4444c7e1be0e3c7a4644cc9cb7b15189cbfcf3e9b367012686de6"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Similarly, NAC prevented increased expression of MHCII, CD14, TNFα, IL-6, IL-1β, and CD86 and mildly compensated for the decrease of CD206 and IL-10 following heme treatment (Figure 4D; supplemental Figure 5).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 24,
      "key": "b1656dc37736caaf3ac851c4ee200db5652d8fd2f60d42c3dfcb7c883cade044a6f1f01387de443de90dd3202d89752df1064d17b2e48c73cb5f6a5a9a053e52"
    },
    {
      "line": 234,
      "relation": "negativeCorrelation",
      "evidence": "Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 0,
      "target": 7,
      "key": "30b27bc2ea466352e8a9b2b500baa73b940119cdb765612f674567ffd59500bb24759908b74975b8254da8a91dc674c46b8bd8372d5f09f2c4e42e8bb019701c"
    },
    {
      "line": 233,
      "relation": "positiveCorrelation",
      "evidence": "Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 3,
      "key": "dd66bb84aeeb7ae7215e3728aa5dee2a90927d62b0ee134bff8cfa62ccfbfd47fbfb0b9f92f0f5fffa671a4abc8b8a90ec9e55f8f8d2d30ebaeb3a091918778c"
    },
    {
      "line": 234,
      "relation": "negativeCorrelation",
      "evidence": "Likewise, NAC was able to prevent iron-induced M1 polarization in M0, M1, and M2 BMDMs (supplemental Figure 13), indicating that the alteration of macrophage plasticity in response to iron is mostly explained by its pro-oxidant properties.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 0,
      "key": "35e7f2a19bb2b65d94cee3cbc6f1d55d4e452deaf0bfa70b7d63465767faa768ff5ee163f5a1a9a23603bdca4c234d9665b4cd648fb5e70770b0397e8e1c7391"
    },
    {
      "line": 259,
      "relation": "negativeCorrelation",
      "evidence": "Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 23,
      "key": "6f599a96d0b2e26c181a36c9f8714159a18ad48beae64eb0b10062ed7a163d0e62bca3a9915cb84bf08cfdbbddb7c0e3a2c11ea2bac72e73ec1a7a01cb3c1c4a"
    },
    {
      "line": 260,
      "relation": "negativeCorrelation",
      "evidence": "Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 2,
      "key": "d2bd9bb05fef5ea6dced3348805d69b1ba3ac40abe9b2d3310dac4eabc34186c7f4e77a7be6b2851560d489f3e2a486ab0382e0801ec18fea768a10638b3a7eb"
    },
    {
      "line": 344,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 34,
      "key": "aff61c6d46822617682ed653fcc7de1b009a763a858a45c11b25d95bb6eff1eab5887bf8509c7d21bb47c80b89ca228859510c6efb2145e0bf1f4abd6623d299"
    },
    {
      "line": 356,
      "relation": "negativeCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 34,
      "key": "988d42cef5e2e57643bb94f44a70b9fa97c8b141364f7da646b32e3321975004ad33f367f9d8f9d99991de96d3247e92e8ccec1c6ab9eb2817027f55d2d3dad4"
    },
    {
      "line": 354,
      "relation": "positiveCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 7,
      "target": 11,
      "key": "398d7e189a38240c79e0da0a10986b1115fe54d750bf40be3d8e28e3413ce03ff449dbf4e1fd7546ec97f371ec6ebd3900377d3fa4002d44e87fbf18be96e798"
    },
    {
      "line": 260,
      "relation": "negativeCorrelation",
      "evidence": "Treatment with Hx or DFO diminished the increase of some M1 polarization markers in BMDMs following treatment with hemolytic RBCs (supplemental Figure 14).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 2,
      "target": 7,
      "key": "9459cbed345e857c64bcc23b6c1b1bf57e89cb5d88d2038794d008a5a9dcdc7246e27a92978a7f19a0835bdf7655efa5f83c6a94bcdad35c9f62a25056a86b60"
    },
    {
      "line": 282,
      "relation": "decreases",
      "evidence": "Here we show that Hx treatment decreases expression of the M1 cytokine TNFα, the monocyte chemoattractant protein (MCP)1, and the profibrotic and mitogenic cytokines transforming growth factor (TGF)β and platelet-derived growth factor (PDGF) in the liver of sickle mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 42,
      "key": "ec86e46f8b07993f5fc06889b600aaf44372b008f184381e1476ede8ecce3ec1d60b6d0b0506dd238f1e240b6b46645efd51f10735fcd4acf96c5341b670435c"
    },
    {
      "line": 283,
      "relation": "decreases",
      "evidence": "Here we show that Hx treatment decreases expression of the M1 cytokine TNFα, the monocyte chemoattractant protein (MCP)1, and the profibrotic and mitogenic cytokines transforming growth factor (TGF)β and platelet-derived growth factor (PDGF) in the liver of sickle mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 32,
      "key": "71a59031bf0472af04a7ed6f427bca2e831e59690d834fea7f3a279465dd32bcbd55b87e51feaee59be6faf7cbc3af73270af64be6677b0eca7464620c56d988"
    },
    {
      "line": 284,
      "relation": "decreases",
      "evidence": "Here we show that Hx treatment decreases expression of the M1 cytokine TNFα, the monocyte chemoattractant protein (MCP)1, and the profibrotic and mitogenic cytokines transforming growth factor (TGF)β and platelet-derived growth factor (PDGF) in the liver of sickle mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 39,
      "key": "9f0541831a09744d987d74044785430321706c71c2766b134d75a6c681ea8331dc81e17647be1f7951bef4a81892177430188ac476df66c790d3cd04d4a19d26"
    },
    {
      "line": 285,
      "relation": "decreases",
      "evidence": "Here we show that Hx treatment decreases expression of the M1 cytokine TNFα, the monocyte chemoattractant protein (MCP)1, and the profibrotic and mitogenic cytokines transforming growth factor (TGF)β and platelet-derived growth factor (PDGF) in the liver of sickle mice.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 45,
      "key": "18406748414694b865aee0d60a466cbf87b83092250c65ef53bc38576b828cb7691ab8a33ca1aa25428d0f0b18ebd27b9ef8b79b9df11d7901aae05cd4e3aefe"
    },
    {
      "line": 291,
      "relation": "increases",
      "evidence": "Moreover, Hx administration increases hepatic expression of the matrix metalloproteinases MMP-9, MMP-12, and MMP-13 (mostly expressed by M2 macrophages).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 37,
      "key": "5b2e9104b313abcfed652959f51a003c37248bd024b9506bf85a357a3697a219aff04b172d012975c66bb605f0914742f68f744ef68673ffc55e23544bb9cc28"
    },
    {
      "line": 292,
      "relation": "increases",
      "evidence": "Moreover, Hx administration increases hepatic expression of the matrix metalloproteinases MMP-9, MMP-12, and MMP-13 (mostly expressed by M2 macrophages).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 35,
      "key": "79ef4df4d83a4883265183958b0071481b4e11eb7f244f9aaf8681af622d19eb802bb2ca2033ae8c441ea3f2c516446e10ef78e1c3c812582d9e9b91e84290fb"
    },
    {
      "line": 293,
      "relation": "increases",
      "evidence": "Moreover, Hx administration increases hepatic expression of the matrix metalloproteinases MMP-9, MMP-12, and MMP-13 (mostly expressed by M2 macrophages).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 36,
      "key": "509634a65b17aee1bf2e3947244de60d1b8093eb9dc86af09da302f84e52367d565b29139ad99605f7f97852be4ebbe5745604c6cd2cf5bc0362d74678feb6e9"
    },
    {
      "line": 299,
      "relation": "decreases",
      "evidence": "It further increases the expression of a marker for resting HSCs, synaptophysin, and reduces the expression of a marker for activated myofibroblast-like HSCs, smooth muscle actin (SMA) (Figure 7B).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 31,
      "key": "33c7f4b59698004ca02b1198427579d989182fe5ce22288d78de1a456857777a6b42a6d0015ab4285a20f49ff89e4fc1cb26c7455324edf0b579d81366228d5f"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "It further increases the expression of a marker for resting HSCs, synaptophysin, and reduces the expression of a marker for activated myofibroblast-like HSCs, smooth muscle actin (SMA) (Figure 7B).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 38,
      "key": "09f755defda18022ed43c07f9d39be627c6ae19a49cdf4e06173e01cca3c500355a28044ac461f75d6724f7aff1986f29ccfb3a787c7ec5e704a22ec26611b1a"
    },
    {
      "line": 318,
      "relation": "negativeCorrelation",
      "evidence": "Taken together, these data suggest that Hx administration decreases heme-driven proinflammatory activation of macrophages.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 11,
      "key": "556ec183010940be326ac20254bb23549ed9369520f1acfca0fffb1bc2a7035bafa8ec883137cdaaf2a317ad40927c1edf01e0e3a576b7bfdef3d1d1fccb94f9"
    },
    {
      "line": 324,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 11,
      "key": "7c005cdec3dbe47e9047c87e49da6e8dcc7d8048eca9b908c652924078b12eb39e6fb084e1f1d0081ff1b8a0b29963740ae87eea7d7bf1725f3cdb8fe241e376"
    },
    {
      "line": 357,
      "relation": "negativeCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 11,
      "key": "955d25aa3aede3b13e8af8c042c436578992349179ff04bfac7c4d34b52114a306240818323dd97acdaebb364182a2abea4a9ab2e58b7c8b7a573bcd846218a4"
    },
    {
      "line": 325,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 47,
      "key": "75a6a65c4c906c5bfdcad53997797c86cb931c302e4b94cd1f80d9983bbc3d12c46ef6077315e86a35c46cc83f3f8aa8815d664bf9d85de48f1441cc7b513fcd"
    },
    {
      "line": 327,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 46,
      "key": "102c628548c157d86456b24e0b8b092c53fb937d342dabd6289d4f5d9c02c94497f7eb7a60a056d63a41a6167467bdaa7cd620ea64fe4b434ce35ce0e5904c36"
    },
    {
      "line": 328,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 13,
      "key": "a89fc0407486e5d27e61be4ec4debabdbbe5cfcc56631cd22620b8a4a1a60e209e084bc1afbbb2417e1fe5946c09e3fb4f1aa7aad436c3bfc8d68d8ad89b1208"
    },
    {
      "line": 344,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 7,
      "key": "6885133638a4aa9e7f0bec6fbbcb1c28d26d9be8238dd502881ba9d8077b444f8159e2d78b6491bf644a9c811845fbd4c7355c5153e2432188b787b4a1c5f32b"
    },
    {
      "line": 356,
      "relation": "negativeCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 7,
      "key": "275d84cd19676f47d28d5ac2ee058550f69db1e2fce29abdbbff8cacff75a6175d76d68cbabc14b86a04316b0fe4e4cf4e4a848df7abbb22637b9cb13bf90177"
    },
    {
      "line": 345,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 34,
      "target": 41,
      "key": "0b974eee5e98b4d9f3155363b2463c166c2d4b57e43005ff104b36ea2802b20fa61b064345aca74ed03005070ae69d3da7a20e5c5c1d6cacea08221630c52bf9"
    },
    {
      "line": 346,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 34,
      "target": 8,
      "key": "71bcdc72276dd4452dffd037e244909c68d9d52f2b861868d3d73b28cef463c92054502f15b86dc45d79161c52fe40611a64d5a3c0d97295dee9b6a154b6a97e"
    },
    {
      "relation": "hasComponent",
      "source": 16,
      "target": 5,
      "key": "9797cd11d305bcc8921fa7052e6ee487d7690cbbd1e0af11fa7933a872483beb306719834421e5ee0a5982f66a460e7a5ee62d5eec215b89210ff12eacb18858"
    },
    {
      "relation": "hasComponent",
      "source": 16,
      "target": 34,
      "key": "ce658cb4409630e3b8606aaf74883f7cf5ba56f65b887c9e8e1c5c91d01d69ad2a36548efeec655a8e871aca224bc3651c8a0c094a2ca97ba8c0afb2eefb762f"
    },
    {
      "line": 307,
      "relation": "decreases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 39,
      "key": "48a403d24306e39253f851cd345f4778560339ea23149177f40cc493fb5c0fb797960381fd4807f412854fc0b9b8ea2145bb802fa7ad63bc98dde7528da30f7f"
    },
    {
      "line": 308,
      "relation": "decreases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 45,
      "key": "2e57299e5c5080e42989811b453f8550377ce98cb397f2d6f299035eb0973ba7beab4a1be539e8d9fb60677fd03425c5d936fe5e068ca51e458046cc12edf427"
    },
    {
      "line": 309,
      "relation": "decreases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 31,
      "key": "9b851354453f8f913fa2a3d4b4ce7c44db9b1fd70ff1a9defc799a3d245b3b59c4a2b113f6ff156dc00f64d8db0df105f42fb179a8d65436d3afc67b33ebaa2a"
    },
    {
      "line": 310,
      "relation": "decreases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 40,
      "key": "2c7063d4abd8fc656e3133a0b7dabd35f87f165776047fdf864b82714d4b19587528b1d588f6e575fbbc92c607f72745b90fbe3a160f374ec057599e30ff5b3f"
    },
    {
      "line": 311,
      "relation": "increases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 33,
      "key": "2256b4067e729c5306398e1fe4e594c6120751db585d6936a15589cc81d7a76927c26842e460809f465864ec2adb0b3cbad85bff181b8b8b711683e1f3f64344"
    },
    {
      "line": 312,
      "relation": "increases",
      "evidence": "We therefore next analyzed heme-Hx-treated wild-type mice that showed decreased hepatic expression of collagens, TGFβ, PDGF, SMA, and the tissue inhibitor of MMPs, TIMP2, as well as increased expression of the M2 polarizing colony stimulating factor-1 and MMPs compared with heme-HSA–treated mice ( Figure 7C).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 16,
      "target": 30,
      "key": "1eeea465b750f15c6c363114cc519e9048935b2bf7edd9f4a2297ce5a13a599ef694df87dfb7cfb718320a776345de911b7678e556d7e0a24a2462cf4ca32466"
    },
    {
      "line": 325,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 47,
      "target": 34,
      "key": "b412981fa05537c19afa44bb808f49ae2048575c9ce9d05dc0d8a0a33b43b9010c56a88b970dc718c45f7c859f9e8048f106d90fef1c795d5fe91c1de81e55c3"
    },
    {
      "line": 355,
      "relation": "positiveCorrelation",
      "evidence": "Our data support the idea that heme-induced phenotypic switching of macrophages toward a proinflammatory phenotype can contribute to the exacerbation of inflammation and chronic tissue injury in hemolytic disorders and that Hx therapy could alleviate these pathophysiologic consequences by preventing macrophage inflammatory activation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 47,
      "target": 11,
      "key": "a53dd15252d85b5e8044f1e3ca87d4c455798b810dc6c311aa294afcbd76e5ef35853724a4da4bee880ec28eb33e260ff7dd5fa5038dcbd190fb79eea1de2719"
    },
    {
      "line": 327,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 46,
      "target": 34,
      "key": "784573114e0b37e03737ccab2fd6b3abc5371d28e75c240b925602ec90d5fc9ff78b2fb6c9db6806be7528fa777f47c0db99a6106007ad1b0f65f09dfdc681f5"
    },
    {
      "line": 328,
      "relation": "negativeCorrelation",
      "evidence": "In conclusion, an Hx-based therapy shows beneficial effects, in that it counteracts heme-induced proinflammatory activation of macrophages and attenuates some of its pathophysiologic consequences, such as chronic inflammation, hepatic fibrosis, and apoptosis (Figure 7E).",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Results": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "source": 13,
      "target": 34,
      "key": "f0ddb4ebc89ba74548012e1cded19ec0a581c3b60f6fd7814444189746bccbf21dd0bc0b278d7c6206ce46bbab3bc7548f68c5ea2e7cf68c9eae2acc66093d91"
    },
    {
      "line": 345,
      "relation": "negativeCorrelation",
      "evidence": "Importantly, by scavenging free heme, Hx prevents heme-induced M1 macrophage polarization and thus avoids both TLR4 activation and ROS formation.",
      "citation": {
        "type": "PubMed",
        "name": "Blood",
        "reference": "26675351",
        "title": "Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.",
        "volume": "127",
        "pages": "473-86",
        "date": "2016-01-28",
        "first": "Vinchi F",
        "last": "Muckenthaler MU",
        "authors": [
          "Brinkman N",
          "Cerwenka A",
          "Costa da Silva M",
          "Ingoglia G",
          "Muckenthaler MU",
          "Petrillo S",
          "Tolosano E",
          "Vinchi F",
          "Zuercher A"
        ]
      },
      "annotations": {
        "TextLocation": {
          "Discussion": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "MeSHAnatomy": {
          "Liver": true
        },
        "Cell": {
          "macrophage": true
        },
        "TimePoint": {
          "15 hours": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 41,
      "target": 34,
      "key": "83c0ac6a65b1579aa762f0155a54745b45e1e54b70187de7ee2eca0d57eac2d1d1cc3625230be3995d192e9e196d21d11cdf7f3457e5119696735f1e590366d1"
    }
  ]
}